Received Apr 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | AHAVB349BA | — |
Expired Dose Administered; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a patient who received HAV (Havrix) (batch number AHAVB349BA) for prophylaxis. On an unknown date, the patient received Havrix. On an unknown date, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: Expired Dose Administered). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 17-APR-2025 CMA (clinic assistant manager) was trying to obtain a lot number for what she stated was a Havrix vaccine. She stated that according to what she was looking at, the vaccine expired in 2006 but was administered in 2010, which led to expired vaccine used. Upon checking the lot number with the batch number tool, it did not pull up as a vaccine. However, the HCP stated that it said Havrix. The Vaccine Administration Facility is the same as Primary Reporter. The reporter declined to provide any patient information and declined followup.